1. Home
  2. CTNT vs APVO Comparison

CTNT vs APVO Comparison

Compare CTNT & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cheetah Net Supply Chain Service Inc.

CTNT

Cheetah Net Supply Chain Service Inc.

HOLD

Current Price

$1.81

Market Cap

4.7M

Sector

N/A

ML Signal

HOLD

Logo Aptevo Therapeutics Inc.

APVO

Aptevo Therapeutics Inc.

HOLD

Current Price

$3.95

Market Cap

5.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTNT
APVO
Founded
2016
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7M
5.1M
IPO Year
2023
2023

Fundamental Metrics

Financial Performance
Metric
CTNT
APVO
Price
$1.81
$3.95
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
364.6K
31.0K
Earning Date
05-08-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
57.74
0.13
EPS
N/A
N/A
Revenue
$1,288,536.00
$3,114,000.00
Revenue This Year
$42.49
N/A
Revenue Next Year
$22.22
N/A
P/E Ratio
N/A
N/A
Revenue Growth
182.69
N/A
52 Week Low
$0.02
$0.50
52 Week High
$4.21
$10.70

Technical Indicators

Market Signals
Indicator
CTNT
APVO
Relative Strength Index (RSI) 54.87 39.18
Support Level $1.47 $3.81
Resistance Level $1.95 $4.84
Average True Range (ATR) 0.16 0.25
MACD 0.03 -0.03
Stochastic Oscillator 70.91 10.00

Price Performance

Historical Comparison
CTNT
APVO

About CTNT Cheetah Net Supply Chain Service Inc.

Cheetah Net Supply Chain Service Inc is a provider of logistics and warehousing services, historically in connection with the sale of parallel-import vehicles sourced in the U.S. to be sold in the PRC market, and more recently for the transportation of other goods between the U.S. and the PRC. Parallel-import vehicles in the PRC refer to automobiles purchased directly from overseas markets and imported for sale outside of the brand manufacturer's official distribution networks. The company operates as single report segment. The company operates in the USA and overseas.

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, CD3xCD123, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Share on Social Networks: